Atlas Trials

Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

Clinical trial NCT00648622 · COMPLETED

Trial details

NCT number
NCT00648622
Sponsor
Mylan Pharmaceuticals Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2004-04-01
Primary completion
2004-04-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.